A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Conditions
Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Louis B Nabors, MD)University of California, San Diego, La Jolla, California, United States
Contact: Principal Investigator (David Piccioni, MD, PhD)Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, United States
Contact: Principal Investigator (Jethro Hu, MD)University of California, Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Phioanh Nghiemphu, MD)St. Joseph Hospital, Orange, California, United States
Contact: Principal Investigator (Lars Anker, MD)University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (UCSF Neuro Onc New Patient Coordinator) · NeuroOncNewPatientCoord@ucsf.edu · (415) 353-2193Contact: Principal Investigator (Nicholas Butowski, MD)Stanford Cancer Center, Stanford, California, United States
University of Colorado Denver, Aurora, Colorado, United States
Contact: Principal Investigator (Denise Damek, MD)Yale Cancer Center / Smilow Cancer Hospital*, New Haven, Connecticut, United States
Contact: Principal Investigator (Nicholas Blondin, MD)Mayo Clinic Cancer Center, Jacksonville, Florida, United States
Sylvester Comprehensive Cancer Center*, Miami, Florida, United States
Contact: Principal Investigator (Macarena I De La Fuente, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Patrick Grogan, MD)Piedmont Atlanta Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Erin Dunbar, MD)Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
LSU Health Sciences Center - New Orleans, New Orleans, Louisiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Patrick Wen, MD)Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Patrick Wen, MD)Henry Ford Health System, Detroit, Michigan, United States
Allina Health Systems/Abbott Northwestern Hospital, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Andrea Wasilewski, MD)Mayo Clinic Cancer Center - Rochester, Rochester, Minnesota, United States
University of Mississippi Medical Center, Jackson, Mississippi, United States
Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Perlmutter Cancer Center, NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Jonathan Yang, MD, PhD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Lyndon Kim, MD)Columbia University Medical Center, New York, New York, United States
Contact: Study coordinator (Andrew Lassman, MD) · cancerclinicaltrials@cumc.columbia.edu · 212-342-0571Contact: Principal Investigator (Andrew Lassman, MD)Memorial Sloan Kettering Cancer Center*, New York, New York, United States
Contact: Principal Investigator (Ingo Mellinghoff, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Katherine Peters, MD, PhD)Comprehensive Cancer Center of Wake Forest*, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Glenn Lesser, MD)University Hospitals Cleveland Medical Center*, Cleveland, Ohio, United States
Contact: Principal Investigator (Herbert Newton, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Mina Lobbous, MD)Ohio State University Cancer Center, Columbus, Ohio, United States
University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (ACC Clinical Trials) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245Contact: Principal Investigator (Arati Desai, MD)Allegheny General Hospital, Pittsburgh, Pennsylvania, United States
University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Jan Drappatz, MD)Medical University of South Carolina - Hollings Cancer Center, Charleston, South Carolina, United States
Contact: Study coordinator (HCC Clinical Trials Office) · hcc-clinical-trials@musc.edu · 843-792-9321Contact: Principal Investigator (Scott Lindhorst, MD)Texas Oncology - Austin, Austin, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Shiao-Pei Weathers, MD)University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Principal Investigator (Howard Colman, MD, PhD)University of Virginia Health, Charlottesville, Virginia, United States
Contact: Principal Investigator (David Schiff, MD)University of Washington Medical Center, Seattle, Washington, United States
Froedtert Hospital/Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Northern Sydney Cancer Centre/Royal North Shore Hospital, St Leonards, New South Wales, Australia
Contact: Principal Investigator (Helen Wheeler, MD)Calvary Mater Newcastle, Waratah, New South Wales, Australia
Contact: Principal Investigator (Faisal Hayat, MD)Royal Brisbane and Women's Hospital, Herston, Queensland, Australia
Contact: Principal Investigator (Zarnie Lwin, MD)Flinders Medical Centre, Bedford Park, South Australia, Australia
Contact: Study coordinator (Monique Swan) · Health.FMCCancerResearchNurse@sa.gov.au · (08) 8404 2702Contact: Principal Investigator (Ganessan Kichenadasse, MD)Austin Health, Heidelberg, Victoria, Australia
Contact: Principal Investigator (Hui Gan, MBBS, FRACP, PhD)Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Principal Investigator (Jim Whittle, MD)Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (James Perry, MD, FRCPC)Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Warren Mason, MD)Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada
Contact: Principal Investigator (Scott Owen, MD)Université de Sherbrooke, Sherbrooke, Quebec, Canada
Centre Hospitalier Lyon Sud / Hôpital Neurologique P. Wertheimer, Bron, France
Contact: Principal Investigator (Francois Ducray, MD)Hopital de la Timone, Marseille, France
Contact: Principal Investigator (Emelie Tabouret, MD)Hopital Piti-Salpetriere, Paris, France
Contact: Principal Investigator (Mehdi Touat, MD)Uniklinik Koeln - Zentrum fuer Neurologie und Psychiatrie, Cologne, Germany
Dr. Senckenbergisches Institut für Neuroonkologie, Frankfurt, Germany
Contact: Study coordinator (Michael Ronellenfitsch, MD,PhD) · m.ronellenfitsch@med.uni-frankfurt.de · +49(0)69 6301 87711Contact: Principal Investigator (Michael Ronellenfitsch, MD, PhD)Universitätsklinik Heidelberg, Heidelberg, Germany
Contact: Principal Investigator (Antje Wick, MD)Universitaetsklinikum Heidelberg - Neurologische Klinik, Mannheim, Germany
Contact: Principal Investigator (Michael Platten, MD)Universitätsklinikum Regensburg, Regensburg, Germany
Contact: Principal Investigator (Peter Hau, MD)Universitätsklinikum Tübingen, Tübingen, Germany
Contact: Study coordinator (Ghazaleh Tabatabai) · Ghazaleh.Tabatabai@med.uni-tuebingen.de · +49 (0)707 12983269Contact: Principal Investigator (Ghazaleh Tabatabai, MD)Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne, Canton of Vaud, Switzerland
Contact: Principal Investigator (Andreas Hottinger, MD)University Hospital Zurich, Zurich, Switzerland
Contact: Principal Investigator (Michael Weller, MD)
Study leads
Tim Cloughesy, MD
Principal Investigator
GCAR CMO and GBM AGILE Global PI